Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kathleen Corey, M.D.

Title
Institution
Department
Address
Fax

Mentoring
Available: 02/18/20, Expires: 02/18/21

The NAFLD Research Program at MGH seeks students to assist and/or lead projects evaluating biomarkers for NAFLD diagnosis, disease progression, comorbidities in NAFLD (ex. cardiovascular disease, obstructive sleep apnea) and NAFLD in persons with HIV. Under the direction of Drs. Kathleen Corey and Tracey Simon, students could engage in data collection, data analysis and manuscript preparation. Interested. Contact Kathleen.corey@mgh.harvard.edu and tgsimon@mgh.harvard.edu


Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01DK114144 (STANLEY, TAKARA LEAH) May 15, 2018 - Apr 30, 2023
    NIH/NIDDK
    Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
    Role: Co-Principal Investigator
  2. R03DK113349 (COREY, KATHLEEN ELIZABETH) Apr 15, 2017 - Mar 31, 2019
    NIH/NIDDK
    Metabolite profiling for Coronary Artery Disease in Nonalcoholic Fatty Liver Disease
    Role: Principal Investigator
  3. K23DK099422 (COREY, KATHLEEN ELIZABETH) Jul 1, 2013 - Jun 30, 2018
    NIH/NIDDK
    The Impact of Obstructive Sleep Apnea on Non-Alcoholic Fatty Liver Disease
    Role: Principal Investigator
  4. F32DK083252 (COREY, KATHLEEN ELIZABETH) Mar 15, 2009 - Mar 14, 2012
    NIH/NIDDK
    Interactions Between Hepatitis C and Serum Lipid Homeostasis
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Verna EC, Serper M, Chu J, Corey K, Fix OK, Hoyt K, Page KA, Loomba R, Li M, Everson GT, Fried MW, Garcia-Tsao G, Terrault N, Lok AS, Chung RT, Reddy KR. Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation. Hepatology. 2020 11; 72(5):1819-1837. PMID: 32740969.
    Citations:    Fields:    
  2. Stanley TL, Fourman LT, Zheng I, McClure CM, Feldpausch MN, Torriani M, Corey KE, Chung RT, Lee H, Kleiner DE, Hadigan CM, Grinspoon SK. Relationship of IGF-1 and IGF Binding Proteins to Disease Severity and Glycemia in Non-Alcoholic Fatty Liver Disease. J Clin Endocrinol Metab. 2020 Oct 30. PMID: 33125080.
    Citations:    
  3. Long MT, Zhang X, Xu H, Liu CT, Corey KE, Chung RT, Loomba R, Benjamin EJ. Hepatic fibrosis associates with multiple cardiometabolic disease risk factors: The Framingham Heart Study. Hepatology. 2020 Oct 30. PMID: 33125745.
    Citations:    
  4. Lake JE, Overton T, Naggie S, Sulkowski M, Loomba R, Kleiner DE, Price JC, Chew KW, Chung RT, Corey KE. Expert Panel Review on Non-Alcoholic Fatty Liver Disease in Persons with HIV. Clin Gastroenterol Hepatol. 2020 Oct 15. PMID: 33069882.
    Citations:    Fields:    
  5. Kim MN, Lo CH, Corey KE, Liu PH, Ma W, Zhang X, Jovani M, Song M, Chan AT, Simon TG. Weight gain during early adulthood, trajectory of body shape and the risk of nonalcoholic fatty liver disease: A prospective cohort study among women. Metabolism. 2020 12; 113:154398. PMID: 33058854.
    Citations:    Fields:    
  6. Li DK, Rehan Khan M, Wang Z, Chongsrisawat V, Swangsak P, Teufel-Schäfer U, Engelmann G, Goldschmidt I, Baumann U, Tokuhara D, Cho Y, Rowland M, Mjelle AB, Ramm GA, Lewindon PJ, Witters P, Cassiman D, Ciuca IM, Prokop LD, Haffar S, Corey KE, Hassan Murad M, Furuya KN, Bazerbachi F. Normal Liver Stiffness and Influencing Factors in Healthy Children: An Individual Participant Data Meta-analysis. Liver Int. 2020 Sep 08. PMID: 32901449.
    Citations:    Fields:    
  7. Fourman LT, Billingsley JM, Agyapong G, Ho Sui SJ, Feldpausch MN, Purdy J, Zheng I, Pan CS, Corey KE, Torriani M, Kleiner DE, Hadigan CM, Stanley TL, Chung RT, Grinspoon SK. Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD. JCI Insight. 2020 Aug 20; 5(16). PMID: 32701508.
    Citations:    Fields:    
  8. Arvind A, Osganian SA, Sjoquist JA, Corey KE, Simon TG. Epoxygenase-Derived Epoxyeicosatrienoic Acid Mediators Are Associated With Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Fibrosis. Gastroenterology. 2020 Aug 05. PMID: 32768596.
    Citations:    Fields:    
  9. Kaplan A, Simon TG, Henson JB, Wang T, Zheng H, Osganian SA, Rosenblatt R, Lake J, Corey KE. Brief Report: Relationship Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in Persons With HIV. . 2020 Aug 01; 84(4):400-404. PMID: 32235172.
    Citations:    
  10. Meyersohn NM, Mayrhofer T, Corey KE, Bittner DO, Staziaki PV, Szilveszter B, Hallett T, Lu MT, Puchner SB, Simon TG, Foldyna B, Voora D, Ginsburg GS, Douglas PS, Hoffmann U, Ferencik M. Association of Hepatic Steatosis With Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease. Clin Gastroenterol Hepatol. 2020 Jul 21. PMID: 32707340.
    Citations:    Fields:    
  11. Younossi ZM, Corey KE, Alkhouri N, Noureddin M, Jacobson I, Lam B, Clement S, Basu R, Gordon SC, Ravendhra N, Puri P, Rinella M, Scudera P, Singal AK, Henry L. Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices. Aliment Pharmacol Ther. 2020 08; 52(3):513-526. PMID: 32598051.
    Citations:    Fields:    
  12. Thayer TE, Lino Cardenas CL, Martyn T, Nicholson CJ, Traeger L, Wunderer F, Slocum C, Sigurslid H, Shakartzi HR, O'Rourke C, Shelton G, Buswell MD, Barnes H, Neitzel LR, Ledsky CD, Li JP, Burke MF, Farber-Eger E, Perrien DS, Kumar R, Corey KE, Wells QS, Bloch KD, Hong CC, Bloch DB, Malhotra R. The Role of Bone Morphogenetic Protein Signaling in Non-Alcoholic Fatty Liver Disease. Sci Rep. 2020 06 19; 10(1):9831. PMID: 32561790.
    Citations:    Fields:    
  13. Danford CJ, Lee JY, Strohbehn IA, Corey KE, Lai M. Development of an Algorithm to Identify Cases of Nonalcoholic Steatohepatitis Cirrhosis in the Electronic Health Record. Dig Dis Sci. 2020 Jun 13. PMID: 32535780.
    Citations:    Fields:    
  14. Steensels S, Qiao J, Zhang Y, Maner-Smith KM, Kika N, Holman CD, Corey KE, Bracken WC, Ortlund EA, Ersoy BA. Acot9 traffics mitochondrial short-chain fatty acids towards de novo lipogenesis and glucose production in the liver. Hepatology. 2020 Jun 04. PMID: 32498134.
    Citations:    Fields:    
  15. Sise ME, Strohbehn I, Chute D, Corey KE, Fusco DN, Sabbisetti VS, Waikar SS, Chung RT. Low Complement C4 Predicts Improvement of Kidney Function After Direct-Acting Antiviral Therapy for Hepatitis C Virus. Hepatol Commun. 2020 Aug; 4(8):1206-1217. PMID: 32766479.
    Citations:    
  16. Henson JB, Corey KE. Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply. Aliment Pharmacol Ther. 2020 05; 51(10):988-989. PMID: 32338780.
    Citations:    Fields:    Translation:Humans
  17. Henson JB, Roden M, Targher G, Corey KE. Is Nonalcoholic Fatty Liver Disease Not a Risk Factor for Cardiovascular Disease: Not Yet Time for a Change of Heart. Hepatology. 2020 May; 71(5):1867-1869. PMID: 32012311.
    Citations:    Fields:    
  18. Fourman LT, Stanley TL, Zheng I, Pan CS, Feldpausch MN, Purdy J, Aepfelbacher J, Buckless C, Tsao A, Corey KE, Chung RT, Torriani M, Kleiner DE, Hadigan CM, Grinspoon SK. Clinical Predictors of Liver Fibrosis Presence and Progression in HIV-Associated NAFLD. Clin Infect Dis. 2020 Apr 09. PMID: 32270862.
    Citations: 1     Fields:    
  19. Henson JB, Simon TG, Kaplan A, Osganian S, Masia R, Corey KE. Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2020 04; 51(7):728-736. PMID: 32043602.
    Citations: 1     Fields:    Translation:Humans
  20. Bethea E, Arvind A, Gustafson J, Andersson K, Pratt D, Bhan I, Thiim M, Corey K, Bloom P, Markmann J, Yeh H, Elias N, Kimura S, Dageforde LA, Cuenca A, Kawai T, Safa K, Williams W, Gilligan H, Sise M, Fishman J, Kotton C, Kim A, Rogers CC, Shao S, Cote M, Irwin L, Myoung P, Chung RT. Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: Implications for therapeutic planning. Am J Transplant. 2020 06; 20(6):1619-1628. PMID: 31887236.
    Citations:    Fields:    
  21. Ozturk A, Mohammadi R, Pierce TT, Kamarthi S, Dhyani M, Grajo JR, Corey KE, Chung RT, Bhan AK, Chhatwal J, Samir AE. Diagnostic Accuracy of Shear Wave Elastography as a Non-invasive Biomarker of High-Risk Non-alcoholic Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease. Ultrasound Med Biol. 2020 Apr; 46(4):972-980. PMID: 32005510.
    Citations:    Fields:    
  22. Simon TG, Kim MN, Luo X, Yang W, Ma Y, Chong DQ, Fuchs CS, Meyerhardt JA, Corey KE, Chung RT, Stampfer M, Zhang X, Giovannucci EL, Chan AT. Physical activity compared to adiposity and risk of liver-related mortality: Results from two prospective, nationwide cohorts. J Hepatol. 2020 Jun; 72(6):1062-1069. PMID: 31954204.
    Citations:    Fields:    
  23. Cai B, Dongiovanni P, Corey KE, Wang X, Shmarakov IO, Zheng Z, Kasikara C, Davra V, Meroni M, Chung RT, Rothlin CV, Schwabe RF, Blaner WS, Birge RB, Valenti L, Tabas I. Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis. Cell Metab. 2020 02 04; 31(2):406-421.e7. PMID: 31839486.
    Citations: 6     Fields:    
  24. Lee M, Lauren BN, Zhan T, Choi J, Klebanoff M, Abu Dayyeh B, Taveras EM, Corey K, Kaplan L, Hur C. The cost-effectiveness of pharmacotherapy and lifestyle intervention in the treatment of obesity. Obes Sci Pract. 2020 Apr; 6(2):162-170. PMID: 32313674.
    Citations:    
  25. Stanley TL, Fourman LT, Feldpausch MN, Purdy J, Zheng I, Pan CS, Aepfelbacher J, Buckless C, Tsao A, Kellogg A, Branch K, Lee H, Liu CY, Corey KE, Chung RT, Torriani M, Kleiner DE, Hadigan CM, Grinspoon SK. Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial. Lancet HIV. 2019 12; 6(12):e821-e830. PMID: 31611038.
    Citations: 3     Fields:    Translation:Humans
  26. Dichtel LE, Schorr M, Loures de Assis C, Rao EM, Sims JK, Corey KE, Kohli P, Sluss PM, McPhaul MJ, Miller KK. Plasma Free Cortisol in States of Normal and Altered Binding Globulins: Implications for Adrenal Insufficiency Diagnosis. J Clin Endocrinol Metab. 2019 10 01; 104(10):4827-4836. PMID: 31009049.
    Citations:    Fields:    Translation:Humans
  27. Carr TA, Okello S, Some FF, Corey KE. Lessons Learned From and Future Opportunities for Global Health Endeavors by 2 Academic Gastroenterology Units. Gastroenterology. 2019 11; 157(5):1177-1179. PMID: 31356806.
    Citations:    Fields:    Translation:Humans
  28. Simon TG, Corey KE. Reply. Clin Gastroenterol Hepatol. 2020 02; 18(2):523-524. PMID: 31352095.
    Citations:    Fields:    
  29. Simon TG, Henson J, Osganian S, Masia R, Chan AT, Chung RT, Corey KE. Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2019 12; 17(13):2776-2784.e4. PMID: 31077838.
    Citations: 6     Fields:    
  30. Ufere NN, Donlan J, Waldman L, Patel A, Dienstag JL, Friedman LS, Corey KE, Hashemi N, Carolan P, Mullen AC, Thiim M, Bhan I, Nipp R, Greer J, Temel J, Chung RT, El-Jawahri A. Physicians' Perspectives on Palliative Care for Patients With End-Stage Liver Disease: A National Survey Study. Liver Transpl. 2019 06; 25(6):859-869. PMID: 30963669.
    Citations: 1     Fields:    Translation:Humans
  31. Alves-Bezerra M, Li Y, Acuña M, Ivanova AA, Corey KE, Ortlund EA, Cohen DE. Thioesterase Superfamily Member 2 Promotes Hepatic VLDL Secretion by Channeling Fatty Acids Into Triglyceride Biosynthesis. Hepatology. 2019 08; 70(2):496-510. PMID: 30516845.
    Citations: 1     Fields:    Translation:HumansAnimals
  32. Udelsman BV, Corey KE, Lindvall C, Gee DW, Meireles OR, Hutter MM, Chang DC, Witkowski ER. Risk factors and prevalence of liver disease in review of 2557 routine liver biopsies performed during bariatric surgery. Surg Obes Relat Dis. 2019 Jun; 15(6):843-849. PMID: 31014948.
    Citations: 1     Fields:    Translation:Humans
  33. Ufere NN, Donlan J, Waldman L, Dienstag JL, Friedman LS, Corey KE, Hashemi N, Carolan P, Mullen AC, Thiim M, Bhan I, Nipp R, Greer JA, Temel JS, Chung RT, El-Jawahri A. Barriers to Use of Palliative Care and Advance Care Planning Discussions for Patients With End-Stage Liver Disease. Clin Gastroenterol Hepatol. 2019 11; 17(12):2592-2599. PMID: 30885884.
    Citations: 3     Fields:    
  34. Corey KE, Wilson LA, Altinbas A, Yates KP, Kleiner DE, Chung RT, Krauss RM, Chalasani N. Relationship between resolution of non-alcoholic steatohepatitis and changes in lipoprotein sub-fractions: a post-hoc analysis of the PIVENS trial. Aliment Pharmacol Ther. 2019 05; 49(9):1205-1213. PMID: 30854694.
    Citations: 2     Fields:    Translation:Humans
  35. Klebanoff MJ, Corey KE, Samur S, Choi JG, Kaplan LM, Chhatwal J, Hur C. Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis. JAMA Netw Open. 2019 02 01; 2(2):e190047. PMID: 30794300.
    Citations: 2     Fields:    Translation:Humans
  36. Simon TG, Ma Y, Ludvigsson JF, Chong DQ, Giovannucci EL, Fuchs CS, Meyerhardt JA, Corey KE, Chung RT, Zhang X, Chan AT. Association Between Aspirin Use and Risk of Hepatocellular Carcinoma. JAMA Oncol. 2018 12 01; 4(12):1683-1690. PMID: 30286235.
    Citations: 19     Fields:    Translation:Humans
  37. Lidofsky A, Holmes JA, Feeney ER, Kruger AJ, Salloum S, Zheng H, Seguin IS, Altinbas A, Masia R, Corey KE, Gustafson JL, Schaefer EA, Hunt PW, Deeks S, Somsouk M, Chew KW, Chung RT, Alatrakchi N. Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection. J Infect Dis. 2018 09 22; 218(9):1394-1403. PMID: 29868909.
    Citations: 7     Fields:    Translation:HumansCells
  38. Vyas JM, Rajagopal J, Sokol CL, Wein MN, Mansour MK, Corey KE, Fishman MC, Armstrong KA. The Great Opportunity: Cultivating Scientific Inquiry in Medical Residency. J Infect Dis. 2018 08 14; 218(suppl_1):S44-S48. PMID: 29878132.
    Citations: 1     Fields:    Translation:Humans
  39. Luther J, Gala MK, Borren N, Masia R, Goodman RP, Moeller IH, DiGiacomo E, Ehrlich A, Warren A, Yarmush ML, Ananthakrishnan A, Corey K, Kaplan LM, Bhatia S, Chung RT, Patel SJ. Hepatic connexin 32 associates with nonalcoholic fatty liver disease severity. Hepatol Commun. 2018 Jul; 2(7):786-797. PMID: 30202815.
    Citations: 2     
  40. Younossi ZM, Loomba R, Anstee QM, Rinella ME, Bugianesi E, Marchesini G, Neuschwander-Tetri BA, Serfaty L, Negro F, Caldwell SH, Ratziu V, Corey KE, Friedman SL, Abdelmalek MF, Harrison SA, Sanyal AJ, Lavine JE, Mathurin P, Charlton MR, Goodman ZD, Chalasani NP, Kowdley KV, George J, Lindor K. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis. Hepatology. 2018 07; 68(1):349-360. PMID: 29222917.
    Citations: 46     Fields:    Translation:Humans
  41. Younossi ZM, Loomba R, Rinella ME, Bugianesi E, Marchesini G, Neuschwander-Tetri BA, Serfaty L, Negro F, Caldwell SH, Ratziu V, Corey KE, Friedman SL, Abdelmalek MF, Harrison SA, Sanyal AJ, Lavine JE, Mathurin P, Charlton MR, Chalasani NP, Anstee QM, Kowdley KV, George J, Goodman ZD, Lindor K. Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 2018 07; 68(1):361-371. PMID: 29222911.
    Citations: 39     Fields:    Translation:Humans
  42. Soti S, Corey KE, Lake JE, Erlandson KM. NAFLD and HIV: Do Sex, Race, and Ethnicity Explain HIV-Related Risk? Curr HIV/AIDS Rep. 2018 06; 15(3):212-222. PMID: 29671204.
    Citations:    Fields:    Translation:HumansCells
  43. Simon TG, Corey KE, Cannon CP, Blazing M, Park JG, O'Donoghue ML, Chung RT, Giugliano RP. The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe. Int J Cardiol. 2018 Nov 01; 270:245-252. PMID: 29903515.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  44. Erstad DJ, Farrar CT, Ghoshal S, Masia R, Ferreira DS, Chen YI, Choi JK, Wei L, Waghorn PA, Rotile NJ, Tu C, Graham-O'Regan KA, Sojoodi M, Li S, Li Y, Wang G, Corey KE, Or YS, Jiang L, Tanabe KK, Caravan P, Fuchs BC. Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP-305, a novel farnesoid X receptor agonist. Hepatol Commun. 2018 Jul; 2(7):821-835. PMID: 30027140.
    Citations: 4     
  45. Simon TG, Trejo MEP, McClelland R, Bradley R, Blaha MJ, Zeb I, Corey KE, Budoff MJ, Chung RT. Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis. Int J Cardiol. 2018 05 15; 259:198-204. PMID: 29579601.
    Citations: 4     Fields:    Translation:Humans
  46. Speliotes EK, Balakrishnan M, Friedman LS, Corey KE. Treatment of Dyslipidemia in Common Liver Diseases. Clin Gastroenterol Hepatol. 2018 08; 16(8):1189-1196. PMID: 29684459.
    Citations: 4     Fields:    Translation:Humans
  47. Simon TG, King LY, Chong DQ, Nguyen LH, Ma Y, VoPham T, Giovannucci EL, Fuchs CS, Meyerhardt JA, Corey KE, Khalili H, Chung RT, Zhang X, Chan AT. Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies. Hepatology. 2018 05; 67(5):1797-1806. PMID: 29152763.
    Citations: 12     Fields:    Translation:Humans
  48. Meoli L, Gupta NK, Saeidi N, Panciotti CA, Biddinger SB, Corey KE, Stylopoulos N. Nonalcoholic fatty liver disease and gastric bypass surgery regulate serum and hepatic levels of pyruvate kinase isoenzyme M2. Am J Physiol Endocrinol Metab. 2018 10 01; 315(4):E613-E621. PMID: 29462566.
    Citations: 1     Fields:    Translation:HumansAnimals
  49. O'Sullivan JF, Morningstar JE, Yang Q, Zheng B, Gao Y, Jeanfavre S, Scott J, Fernandez C, Zheng H, O'Connor S, Cohen P, Vasan RS, Long MT, Wilson JG, Melander O, Wang TJ, Fox C, Peterson RT, Clish CB, Corey KE, Gerszten RE. Dimethylguanidino valeric acid is a marker of liver fat and predicts diabetes. J Clin Invest. 2017 12 01; 127(12):4394-4402. PMID: 29083323.
    Citations: 16     Fields:    Translation:Humans
  50. Danford CJ, Sanchez JE, Corey KE. Managing the Burden of Non-NASH NAFLD. Curr Hepatol Rep. 2017 Dec; 16(4):326-334. PMID: 29503789.
    Citations:    
  51. Kartoun U, Corey KE, Simon TG, Zheng H, Aggarwal R, Ng K, Shaw SY. The MELD-Plus: A generalizable prediction risk score in cirrhosis. PLoS One. 2017; 12(10):e0186301. PMID: 29069090.
    Citations: 4     Fields:    Translation:Humans
  52. Butt AA, Yan P, Chew KW, Currier J, Corey K, Chung RT, Shuaib A, Abou-Samra AB, Butler J, Freiberg MS. Risk of Acute Myocardial Infarction Among Hepatitis C Virus (HCV)-Positive and HCV-Negative Men at Various Lipid Levels: Results From ERCHIVES. Clin Infect Dis. 2017 Aug 15; 65(4):557-565. PMID: 28444148.
    Citations: 5     Fields:    Translation:Humans
  53. Simon TG, Bamira DG, Chung RT, Weiner RB, Corey KE. Nonalcoholic Steatohepatitis is Associated with Cardiac Remodeling and Dysfunction. Obesity (Silver Spring). 2017 08; 25(8):1313-1316. PMID: 28745025.
    Citations: 5     Fields:    Translation:Humans
  54. Simon TG, Kartoun U, Zheng H, Chan AT, Chung RT, Shaw S, Corey KE. MELD-Na score predicts incident major cardiovascular events, in patients with nonalcoholic fatty liver disease (NAFLD). Hepatol Commun. 2017 Jul; 1(5):429-438. PMID: 29085919.
    Citations:    
  55. Schaefer E, Wu W, Mark C, Yang A, DiGiacomo E, Carlton-Smith C, Salloum S, Brisac C, Lin W, Corey KE, Chung RT. Intermittent hypoxia is a proinflammatory stimulus resulting in IL-6 expression and M1 macrophage polarization. Hepatol Commun. 2017 06; 1(4):326-337. PMID: 29404462.
    Citations: 3     
  56. Kimberly WT, O'Sullivan JF, Nath AK, Keyes M, Shi X, Larson MG, Yang Q, Long MT, Vasan R, Peterson RT, Wang TJ, Corey KE, Gerszten RE. Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis. JCI Insight. 2017 May 04; 2(9). PMID: 28469090.
    Citations: 8     Fields:    
  57. Pulli B, Wojtkiewicz G, Iwamoto Y, Ali M, Zeller MW, Bure L, Wang C, Choi Y, Masia R, Guimaraes AR, Corey KE, Chen JW. Molecular MR Imaging of Myeloperoxidase Distinguishes Steatosis from Steatohepatitis in Nonalcoholic Fatty Liver Disease. Radiology. 2017 08; 284(2):390-400. PMID: 28358240.
    Citations: 5     Fields:    Translation:HumansAnimals
  58. Dhyani M, Grajo JR, Bhan AK, Corey K, Chung R, Samir AE. Validation of Shear Wave Elastography Cutoff Values on the Supersonic Aixplorer for Practical Clinical Use in Liver Fibrosis Staging. Ultrasound Med Biol. 2017 06; 43(6):1125-1133. PMID: 28341490.
    Citations: 3     Fields:    Translation:Humans
  59. Corey KE, Gawrieh S, deLemos AS, Zheng H, Scanga AE, Haglund JW, Sanchez J, Danford CJ, Comerford M, Bossi K, Munir S, Chalasani N, Wattacheril J. Risk factors for hepatocellular carcinoma in cirrhosis due to nonalcoholic fatty liver disease: A multicenter, case-control study. World J Hepatol. 2017 Mar 08; 9(7):385-390. PMID: 28321274.
    Citations: 4     
  60. Klebanoff MJ, Corey KE, Chhatwal J, Kaplan LM, Chung RT, Hur C. Bariatric surgery for nonalcoholic steatohepatitis: A clinical and cost-effectiveness analysis. Hepatology. 2017 04; 65(4):1156-1164. PMID: 27880977.
    Citations: 6     Fields:    Translation:Humans
  61. Kedrin D, Gandhi SC, Wolf M, Roper J, Yilmaz O, Corey K, Khalili H, Stanford FC, Gala M. Bariatric Surgery Prior to Index Screening Colonoscopy Is Associated With a Decreased Rate of Colorectal Adenomas in Obese Individuals. Clin Transl Gastroenterol. 2017 Feb 09; 8(2):e73. PMID: 28181993.
    Citations: 1     Fields:    
  62. Klebanoff MJ, Chhatwal J, Nudel JD, Corey KE, Kaplan LM, Hur C. Cost-effectiveness of Bariatric Surgery in Adolescents With Obesity. JAMA Surg. 2017 02 01; 152(2):136-141. PMID: 27784062.
    Citations: 6     Fields:    Translation:Humans
  63. Dichtel LE, Corey KE, Misdraji J, Bredella MA, Schorr M, Osganian SA, Young BJ, Sung JC, Miller KK. The Association Between IGF-1 Levels and the Histologic Severity of Nonalcoholic Fatty Liver Disease. Clin Transl Gastroenterol. 2017 Jan 26; 8(1):e217. PMID: 28125073.
    Citations: 10     Fields:    
  64. Samur S, Klebanoff M, Banken R, Pratt DS, Chapman R, Ollendorf DA, Loos AM, Corey K, Hur C, Chhatwal J. Long-term clinical impact and cost-effectiveness of obeticholic acid for the treatment of primary biliary cholangitis. Hepatology. 2017 03; 65(3):920-928. PMID: 27906472.
    Citations: 7     Fields:    Translation:Humans
  65. Stanford FC, Alfaris N, Gomez G, Ricks ET, Shukla AP, Corey KE, Pratt JS, Pomp A, Rubino F, Aronne LJ. The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: A multi-center study. Surg Obes Relat Dis. 2017 Mar; 13(3):491-500. PMID: 27986587.
    Citations: 14     Fields:    Translation:Humans
  66. Wang X, Zheng Z, Caviglia JM, Corey KE, Herfel TM, Cai B, Masia R, Chung RT, Lefkowitch JH, Schwabe RF, Tabas I. Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis. Cell Metab. 2016 12 13; 24(6):848-862. PMID: 28068223.
    Citations: 34     Fields:    Translation:HumansAnimalsCells
  67. Simon TG, Corey KE, Chung RT, Giugliano R. Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe. Dig Dis Sci. 2016 12; 61(12):3425-3435. PMID: 27714510.
    Citations: 1     Fields:    Translation:Humans
  68. Maffazioli GD, Stanford FC, Campoverde Reyes KJ, Stanley TL, Singhal V, Corey KE, Pratt JS, Bredella MA, Misra M. Comparing Outcomes of Two Types of Bariatric Surgery in an Adolescent Obese Population: Roux-en-Y Gastric Bypass vs. Sleeve Gastrectomy. Front Pediatr. 2016; 4:78. PMID: 27508205.
    Citations: 2     
  69. Okello S, Churchill C, Owori R, Nasasira B, Tumuhimbise C, Abonga CL, Mutiibwa D, Christiani DC, Corey KE. Population attributable fraction of Esophageal squamous cell carcinoma due to smoking and alcohol in Uganda. BMC Cancer. 2016 07 11; 16:446. PMID: 27400987.
    Citations: 8     Fields:    Translation:Humans
  70. Sanchez JE, Corey KE. Interpretation of abnormal liver chemistries in the hospitalized patient. Clin Liver Dis (Hoboken). 2016 Jun; 7(6):132-134. PMID: 31041047.
    Citations:    
  71. Corey KE, Rinella ME. Medical and Surgical Treatment Options for Nonalcoholic Steatohepatitis. Dig Dis Sci. 2016 May; 61(5):1387-97. PMID: 26942734.
    Citations: 9     Fields:    Translation:Humans
  72. Corey KE, Kartoun U, Zheng H, Chung RT, Shaw SY. Using an Electronic Medical Records Database to Identify Non-Traditional Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease. Am J Gastroenterol. 2016 05; 111(5):671-6. PMID: 26925881.
    Citations: 6     Fields:    Translation:Humans
  73. Mueller JL, King LY, Johnson KB, Gao T, Nephew LD, Kothari D, Simpson MA, Zheng H, Wei L, Corey KE, Misdraji J, Lee JH, Lin MV, Gogela NA, Fuchs BC, Tanabe KK, Gordon FD, Curry MP, Chung RT. Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study. Clin Transplant. 2016 Apr; 30(4):452-60. PMID: 26854475.
    Citations:    Fields:    Translation:HumansCells
  74. Corey KE, Klebanoff MJ, Tramontano AC, Chung RT, Hur C. Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis. Dig Dis Sci. 2016 07; 61(7):2108-17. PMID: 26825843.
    Citations: 9     Fields:    Translation:Humans
  75. Bertero T, Cottrill KA, Annis S, Bhat B, Gochuico BR, Osorio JC, Rosas I, Haley KJ, Corey KE, Chung RT, Nelson Chau B, Chan SY. A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions. Sci Rep. 2015 Dec 15; 5:18277. PMID: 26667495.
    Citations: 19     Fields:    Translation:HumansAnimalsCells
  76. Corey KE, Kartoun U, Zheng H, Shaw SY. Development and Validation of an Algorithm to Identify Nonalcoholic Fatty Liver Disease in the Electronic Medical Record. Dig Dis Sci. 2016 Mar; 61(3):913-9. PMID: 26537487.
    Citations: 9     Fields:    Translation:Humans
  77. Mueller JL, Feeney ER, Zheng H, Misdraji J, Kruger AJ, Alatrakchi N, King LY, Gelrud L, Corey KE, Chung RT. Circulating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver Disease. Clin Transl Gastroenterol. 2015 Oct 08; 6:e114. PMID: 26448455.
    Citations: 10     Fields:    
  78. Hundemer GL, Sise ME, Wisocky J, Ufere N, Friedman LS, Corey KE, Chung RT. Use of sofosbuvir-based direct-acting antiviral therapy for hepatitis C viral infection in patients with severe renal insufficiency. Infect Dis (Lond). 2015; 47(12):924-9. PMID: 26365684.
    Citations: 12     Fields:    Translation:HumansCells
  79. Corey KE, Misdraji J, Gelrud L, King LY, Zheng H, Malhotra A, Chung RT. Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology. Dig Dis Sci. 2015 Aug; 60(8):2523-8. PMID: 25840922.
    Citations: 14     Fields:    Translation:Humans
  80. Corey KE, Vuppalanchi R, Vos M, Kohli R, Molleston JP, Wilson L, Unalp-Arida A, Cummings OW, Lavine JE, Chalasani N. Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2015 Mar; 60(3):360-7. PMID: 25714579.
    Citations: 9     Fields:    Translation:Humans
  81. King LY, Johnson KB, Zheng H, Wei L, Gudewicz T, Hoshida Y, Corey KE, Ajayi T, Ufere N, Baumert TF, Chan AT, Tanabe KK, Fuchs BC, Chung RT. Host genetics predict clinical deterioration in HCV-related cirrhosis. PLoS One. 2014; 9(12):e114747. PMID: 25504078.
    Citations: 4     Fields:    Translation:Humans
  82. Corey KE, Vuppalanchi R, Wilson LA, Cummings OW, Chalasani N. NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non-HDL-C levels. Aliment Pharmacol Ther. 2015 Feb; 41(3):301-9. PMID: 25429853.
    Citations: 12     Fields:    Translation:Humans
  83. Samir AE, Dhyani M, Vij A, Bhan AK, Halpern EF, Méndez-Navarro J, Corey KE, Chung RT. Shear-wave elastography for the estimation of liver fibrosis in chronic liver disease: determining accuracy and ideal site for measurement. Radiology. 2015 Mar; 274(3):888-96. PMID: 25393946.
    Citations: 37     Fields:    Translation:Humans
  84. Hunt DP, Sahani DV, Corey KE, Masia R. Case records of the Massachusetts General Hospital. Case 30-2014. A 29-year-old man with diarrhea, nausea, and weight loss. N Engl J Med. 2014 Sep 25; 371(13):1238-47. PMID: 25251619.
    Citations:    Fields:    Translation:Humans
  85. Wright AP, Desai AP, Bajpai S, King LY, Sahani DV, Corey KE. Gaps in recognition and evaluation of incidentally identified hepatic steatosis. Dig Dis Sci. 2015 Feb; 60(2):333-8. PMID: 25190263.
    Citations: 4     Fields:    Translation:Humans
  86. Wright AP, Adusumalli S, Corey KE. Statin therapy in patients with cirrhosis. Frontline Gastroenterol. 2015 Oct; 6(4):255-261. PMID: 28839820.
    Citations: 1     
  87. Corey KE, Misdraji J, Gelrud L, Zheng H, Chung RT, Krauss RM. Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile. Lipids Health Dis. 2014 Jun 21; 13:100. PMID: 24952382.
    Citations: 7     Fields:    Translation:Humans
  88. Corey KE, Stanley TL, Misdraji J, Scirica C, Pratt J, Hoppin A, Misra M. Prevalence and outcome of non-alcoholic fatty liver disease in adolescents and young adults undergoing weight loss surgery. Pediatr Obes. 2014 Oct; 9(5):e91-3. PMID: 24677740.
    Citations: 2     Fields:    Translation:Humans
  89. Corey KE, Kaplan LM. Obesity and liver disease: the epidemic of the twenty-first century. Clin Liver Dis. 2014 Feb; 18(1):1-18. PMID: 24274861.
    Citations: 22     Fields:    Translation:HumansPHPublic Health
  90. Corey KE, Gupta NK, Agarwal S, Xiao HD. Case records of the Massachusetts General Hospital. Case 32-2013. A 55-year-old woman with autoimmune hepatitis, cirrhosis, anorexia, and abdominal pain. N Engl J Med. 2013 Oct 17; 369(16):1545-53. PMID: 24131180.
    Citations: 1     Fields:    Translation:HumansAnimals
  91. Johnson KB, Campbell EJ, Chi H, Zheng H, King LY, Wu Y, Delemos A, Hurairah A, Corey K, Richter JM, Chung RT. Advanced disease, diuretic use, and marital status predict hospital admissions in an ambulatory cirrhosis cohort. Dig Dis Sci. 2014 Jan; 59(1):174-82. PMID: 23990035.
    Citations: 6     Fields:    Translation:Humans
  92. Corey KE, Chalasani N. Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2014 Jul; 12(7):1077-84; quiz e59-60. PMID: 23962548.
    Citations: 11     Fields:    Translation:Humans
  93. Canavan C, Eisenburg J, Meng L, Corey K, Hur C. Ultrasound elastography for fibrosis surveillance is cost effective in patients with chronic hepatitis C virus in the UK. Dig Dis Sci. 2013 Sep; 58(9):2691-704. PMID: 23720196.
    Citations: 13     Fields:    Translation:HumansPHPublic Health
  94. Corey KE, Misdraji J, Zheng H, Malecki KM, Kneeman J, Gelrud L, Chung RT. The absence of obstructive sleep apnea may protect against non-alcoholic fatty liver in patients undergoing bariatric surgery. PLoS One. 2013; 8(5):e62504. PMID: 23658732.
    Citations: 7     Fields:    Translation:Humans
  95. Sinha M, Stanley TL, Webb J, Scirica C, Corey K, Pratt J, Boepple PA, Hoppin A, Misra M. Metabolic effects of Roux-en-Y gastric bypass in obese adolescents and young adults. J Pediatr Gastroenterol Nutr. 2013 May; 56(5):528-31. PMID: 23274343.
    Citations: 3     Fields:    Translation:Humans
  96. Chung RT, Gordon FD, Curry MP, Schiano TD, Emre S, Corey K, Markmann JF, Hertl M, Pomposelli JJ, Pomfret EA, Florman S, Schilsky M, Broering TJ, Finberg RW, Szabo G, Zamore PD, Khettry U, Babcock GJ, Ambrosino DM, Leav B, Leney M, Smith HL, Molrine DC. Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study. Am J Transplant. 2013 Apr; 13(4):1047-1054. PMID: 23356386.
    Citations: 40     Fields:    Translation:HumansCells
  97. Corey KE, Vuppalanchi R. Assessment and management of comorbidities (including cardiovascular disease) in patients with nonalcoholic fatty liver disease. Clin Liver Dis (Hoboken). 2012 Sep; 1(4):114-116. PMID: 31186864.
    Citations:    
  98. Kneeman JM, Misdraji J, Corey KE. Secondary causes of nonalcoholic fatty liver disease. Therap Adv Gastroenterol. 2012 May; 5(3):199-207. PMID: 22570680.
    Citations: 48     
  99. Rodgers MA, Villareal VA, Schaefer EA, Peng LF, Corey KE, Chung RT, Yang PL. Lipid metabolite profiling identifies desmosterol metabolism as a new antiviral target for hepatitis C virus. J Am Chem Soc. 2012 Apr 25; 134(16):6896-9. PMID: 22480142.
    Citations: 16     Fields:    Translation:HumansCells
  100. Corey KE, Zheng H, Mendez-Navarro J, Delgado-Borrego A, Dienstag JL, Chung RT. Serum vitamin D levels are not predictive of the progression of chronic liver disease in hepatitis C patients with advanced fibrosis. PLoS One. 2012; 7(2):e27144. PMID: 22359532.
    Citations: 14     Fields:    Translation:Humans
  101. Corey KE, Lai M, Gelrud LG, Misdraji J, Barlow LL, Zheng H, Andersson KL, Thiim M, Pratt DS, Chung RT. Non-high-density lipoprotein cholesterol as a biomarker for nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol. 2012 Jun; 10(6):651-6. PMID: 22330232.
    Citations: 19     Fields:    Translation:Humans
  102. Corey KE, Chalasani N. Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials? Hepatology. 2011 Nov; 54(5):1503-5. PMID: 21953015.
    Citations:    Fields:    Translation:Humans
  103. Patwardhan V, Paul S, Corey KE, Mazhar SM, Richter JM, Thiim M, Chung RT. Hepatocellular carcinoma screening rates vary by etiology of cirrhosis and involvement of gastrointestinal sub-specialists. Dig Dis Sci. 2011 Nov; 56(11):3316-22. PMID: 21805170.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  104. Corey KE, Mendez-Navarro J, Barlow LL, Patwardhan V, Zheng H, Kim AY, Lauer GM, Chung RT. Acute hepatitis C infection lowers serum lipid levels. J Viral Hepat. 2011 Jul; 18(7):e366-71. PMID: 21692949.
    Citations: 7     Fields:    Translation:HumansCells
  105. Méndez-Navarro J, Corey KE, Zheng H, Barlow LL, Jang JY, Lin W, Zhao H, Shao RX, McAfee SL, Chung RT. Hepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy. Liver Int. 2011 Mar; 31(3):330-9. PMID: 20738779.
    Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
  106. Méndez-Navarro J, Chirino RA, Corey KE, Gorospe EC, Zheng H, Morán S, Juarez JA, Chung RT, Dehesa-Violante M. A randomized controlled trial of double versus triple therapy with amantadine for genotype 1 chronic hepatitis C in Latino patients. Dig Dis Sci. 2010 Sep; 55(9):2629-35. PMID: 19960257.
    Citations: 3     Fields:    Translation:HumansCells
  107. Corey KE, Servoss JC, Casson DR, Kim AY, Robbins GK, Franzini J, Twitchell K, Loomis SC, Abraczinskas DR, Terella AM, Dienstag JL, Chung RT. Pilot study of postexposure prophylaxis for hepatitis C virus in healthcare workers. Infect Control Hosp Epidemiol. 2009 Oct; 30(10):1000-5. PMID: 19743901.
    Citations: 2     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
  108. Corey KE, Kane E, Munroe C, Barlow LL, Zheng H, Chung RT. Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up. Hepatology. 2009 Oct; 50(4):1030-7. PMID: 19787818.
    Citations: 54     Fields:    Translation:HumansCells
  109. Corey KE, Mendez-Navarro J, Gorospe EC, Zheng H, Chung RT. Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis. J Viral Hepat. 2010 Mar; 17(3):201-7. PMID: 19674285.
    Citations: 24     Fields:    Translation:Humans
  110. Corey KE, Shah N, Misdraji J, Abu Dayyeh BK, Zheng H, Bhan AK, Chung RT. The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C. Liver Int. 2009 May; 29(5):748-53. PMID: 19220742.
    Citations: 25     Fields:    Translation:Humans
  111. Corey KE, Pratt DS. Current status of therapy for hepatocellular carcinoma. Therap Adv Gastroenterol. 2009 Jan; 2(1):45-57. PMID: 21180533.
    Citations: 6     
  112. Corey KE, Chung RT. Treating difficult-to-treat hepatitis C virus infection: we may still need to push the ribavirin envelope. Gastroenterology. 2007 Dec; 133(6):2062-3. PMID: 18054581.
    Citations:    Fields:    
  113. Corey KE, Ross AS, Wurcel A, Schulze Zur Wiesch J, Kim AY, Lauer GM, Chung RT. Outcomes and treatment of acute hepatitis C virus infection in a United States population. Clin Gastroenterol Hepatol. 2006 Oct; 4(10):1278-82. PMID: 16931171.
    Citations: 16     Fields:    Translation:HumansCells
  114. Corey KE, Schmitz SM, Shaheen NJ. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis. Am J Gastroenterol. 2003 Nov; 98(11):2390-4. PMID: 14638338.
    Citations: 40     Fields:    Translation:Humans
  115. Corey KE, Maynard C, Pahlm O, Wilkins ML, Anderson ST, Cerqueira MD, Pryor AD, Raitt MH, Startt Selvester RH, Turner J, Weaver WD, Wagner GS. Combined historical and electrocardiographic timing of acute anterior and inferior myocardial infarcts for prediction of reperfusion achievable size limitation. Am J Cardiol. 1999 Mar 15; 83(6):826-31. PMID: 10190393.
    Citations: 2     Fields:    Translation:Humans
  116. LAUGHLIN JS, BEATTIE JW, COREY K, ISAACSON A, KENNY P. Total body scanner for high energy gamma rays. Radiology. 1960 Jan; 74:108. PMID: 14414520.
    Citations: 1     Fields:    
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Corey's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (353)
Explore
_
Co-Authors (136)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.